Former Executive Vice President, Research & Development · BIOGEN INC. (BIIB)

Alfred Sandrock

A named executive officer of BIOGEN in every fiscal year CompBrief holds from FY2019 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$5,737,900

Salary $921,621Stock awards $4,475,590

FY2020: $6,226,969

4th of 5 named executive officers at Biogen by FY2021 total.

5 named officers on file for BIOGEN, FY2021

Alfred Sandrock’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 6 equity grants, each cited to its filing
  • BIIB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIOGEN’s whole pay program stands against its peers

  • BIOGEN’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIIB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Alfred Sandrock’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Alfred Sandrock compensation by year

BIOGEN Summary Compensation Table · all 3 fiscal years held
In US dollars, as BIOGEN reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021
Salary$798,723$890,310$921,621
Bonus$0$0$0
Stock awards$3,360,682$4,331,654$4,475,590
Option awards$0$0$0
Non-equity incentive$893,038$719,541$0
Pension and deferred compensation$78,506$138,444$193,267
All other$181,616$147,020$147,422
Total$5,312,565$6,226,969$5,737,900

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 29, 2022, accession 0001193125-22-130205, and prior-year filings.

How this page was built: the BIOGEN INC. filed document, accession 0001193125-22-130205. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$5.3M
$6.2M
$5.7M
FY19
FY20
FY21
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
PSU7,250$1,739,420—
PSU6,284$1,507,657—
RSU5,713$1,370,663—
PSU4,435$1,064,045—
PSU4,021$964,718—
RSU1,948$467,364—
PSU1,723$413,382—
RSU1,497$359,160—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIOGEN INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

BIOGEN’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Michel VounatsosChief Executive Officer$17,689,665
Michael McDonnellExecutive Vice President, Chief Financial Officer$5,918,371
Chirfi GuindoExecutive Vice President, Chief Commercial Officer$5,750,662
Alfred Sandrock · this pageFormer Executive Vice President, Research & Development$5,737,900
Susan AlexanderExecutive Vice President, Chief Legal Officer And Secretary$5,639,306

The full BIOGEN compensation record

free company brief

This page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOGEN proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Alfred Sandrock's compensation dossier · One-time report. No refunds.